BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18409234)

  • 1. Cardiovascular diabetology: clinical, metabolic and inflammatory facets. Preface.
    Fisman EZ; Tenenbaum A
    Adv Cardiol; 2008; 45():xi-xiii. PubMed ID: 18409234
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
    Koh KK; Han SH; Quon MJ
    J Am Coll Cardiol; 2005 Dec; 46(11):1978-85. PubMed ID: 16325028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
    Rana JS; Nieuwdorp M; Jukema JW; Kastelein JJ
    Diabetes Obes Metab; 2007 May; 9(3):218-32. PubMed ID: 17391148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome, diabetes and lung dysfunction.
    Tiengo A; Fadini GP; Avogaro A
    Diabetes Metab; 2008 Nov; 34(5):447-54. PubMed ID: 18829364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and cardiovascular disease: related disorders created by disturbances in the endogenous clock.
    Scott EM; Carter AM; Grant PJ
    J Indian Med Assoc; 2008 Nov; 106(11):736-8, 740. PubMed ID: 19368099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Obesity, diabetes mellitus and metabolic syndrome: the implications for heart and the vascular system].
    Maisch B
    Herz; 2006 May; 31(3):185-8. PubMed ID: 16770553
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing.
    Schroen B; Heymans S
    Cardiovasc Res; 2012 Mar; 93(4):605-13. PubMed ID: 21994347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome: diabetes and cardiovascular disease.
    Gupta S; Gupta BM
    Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The polycystic ovary syndrome--metabolic consequences].
    Tan S; Hahn S; Janssen OE
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):16-23. PubMed ID: 18209495
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic syndrome: collapsing under its own weight?
    Preiss D; Sattar N
    Diabet Med; 2009 May; 26(5):457-9. PubMed ID: 19646182
    [No Abstract]   [Full Text] [Related]  

  • 12. [Forms of obesity and metabolic disorders].
    Vague J; Vague P; Jubelin J; Barré A
    Verh Dtsch Ges Inn Med; 1987; 93():448-62. PubMed ID: 3327296
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity, metabolic syndrome, and cardiovascular disease.
    Grundy SM
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2595-600. PubMed ID: 15181029
    [No Abstract]   [Full Text] [Related]  

  • 14. [RTH new index or valid clinical marker of diabetes and vascular risk].
    Isnard F; André P
    Journ Annu Diabetol Hotel Dieu; 1993; ():375-91. PubMed ID: 8331875
    [No Abstract]   [Full Text] [Related]  

  • 15. Go to the head of the class to avoid vascular dementia and skip diabetes and obesity.
    Knopman DS
    Neurology; 2008 Sep; 71(14):1046-7. PubMed ID: 18824669
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship between dietary fat and fatty acid intake and body weight, diabetes, and the metabolic syndrome.
    Melanson EL; Astrup A; Donahoo WT
    Ann Nutr Metab; 2009; 55(1-3):229-43. PubMed ID: 19752544
    [No Abstract]   [Full Text] [Related]  

  • 17. Special report on the Sanofi-Aventis cardiometabolic symposium.
    Cardiovasc J Afr; 2007; 18(3):192-5, 198-200, 202. PubMed ID: 17612757
    [No Abstract]   [Full Text] [Related]  

  • 18. [COPD and concomitant diseases].
    Dierkesmann R; Gillissen A; Köhnlein T; Lorenz J; Magnussen H; Morr H; Pfeifer M; Schultze-Werninghaus G; Steinkamp G; Taube C; Teschler H; Vogelmeier C; Worth H
    Pneumologie; 2009 Sep; 63(9):526-37. PubMed ID: 19750413
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease.
    Roos CJ; Quax PH; Jukema JW
    Biomark Med; 2012 Feb; 6(1):35-52. PubMed ID: 22296195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the "domino effect" of the metabolic syndrome.
    Freeman JS
    J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):inside front cover, S1-3. PubMed ID: 17784528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.